radioligand production

Novartis Invests $100M to Revolutionize Cancer Therapy

📢 Novartis is investing $100 million in expanding radioligand production in Indianapolis, supporting targeted therapies for prostate cancer. 🏥 🎯 This investment will create 100 new jobs, as Novartis aims to become a leader in radioligand therapy production. 💼